• Explore /
  • Poster
  • / Retrospective observational study of sunitinib administered on schedule 2/1 in patients with metastatic renal cell carcinoma (mRCC): The rainbow study.

Retrospective observational study of sunitinib administered on schedule 2/1 in patients with metastatic renal cell carcinoma (mRCC): The rainbow study.

Abstract Poster

Authors

null

Sergio Bracarda

Ospedale San Donato USL8, Istituto Toscano Tumori (ITT), Arezzo, Italy

Sergio Bracarda , Roberto Iacovelli , Mimma Rizzo , Marta Rossi , Luca Galli , Giuseppe Procopio , Flavia Longo , Matteo Santoni , Franco Morelli , Giuseppe di Lorenzo , Camillo Porta , Andrea Camerini , Sara Di Bella , Angelo Martignetti , Donatello Gasparro , Roberto Sabbatini , Giovanni Luca Ceresoli , Alessandra Mosca , Daniele Santini , Luca Boni

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Renal Cancer

Track

Renal Cell Cancer

Sub Track

Renal Cell Cancer

Citation

J Clin Oncol 32, 2014 (suppl 4; abstr 471)

DOI

10.1200/jco.2014.32.4_suppl.471

Abstract #

471

Poster Bd #

F4

Abstract Disclosures

Similar Posters

Poster

2011 ASCO Annual Meeting

Phase II trial of sunitinib in renal cell cancer with untreated brain metastases.

Phase II trial of sunitinib in renal cell cancer with untreated brain metastases.

First Author: C. Chevreau

First Author: Ana-Alicia Beltran-Bless

First Author: Antoine Thiery-Vuillemin

First Author: Sam Wong